Skip to main content
logo
Gin Hwa Biotech Incorporation (TPEX:7806)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
60.90
0.00 (0.00%)
At close: Sep 2, 2026

TPEX:7806 Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Cash & Equivalents
74.71117.65116.51
Cash & Short-Term Investments
74.71117.65116.51
Cash Growth
-0.98%-
Accounts Receivable
119.43152.55108.79
Other Receivables
0.90.152.36
Receivables
120.32152.7111.15
Inventory
95.2989.3982.21
Other Current Assets
93.4985.29.02
Total Current Assets
383.81444.95318.89
Property, Plant & Equipment
700.34632.33416.65
Other Intangible Assets
7.338.379.12
Long-Term Deferred Tax Assets
2.712.361.34
Other Long-Term Assets
26.7518.9714.4
Total Assets
1,1211,107760.4

Liabilities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Accounts Payable
35.0927.8932.72
Current Portion of Long-Term Debt
24.544.5-
Current Portion of Leases
5.469.928.46
Current Income Taxes Payable
15.2120.636.95
Current Unearned Revenue
0.7511.464.51
Other Current Liabilities
134.5759.262.55
Total Current Liabilities
215.58173.59115.18
Long-Term Debt
127.19153.29163.84
Long-Term Leases
3.585.929.13
Total Liabilities
346.34332.81288.15

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Common Stock
278.6278.6238.6
Additional Paid-In Capital
357.76357.76147.3
Retained Earnings
124.32137.8286.35
Shareholders' Equity
774.6774.18472.25
Total Liabilities & Equity
1,1211,107760.4

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Total Debt
160.73213.63181.43
Net Cash (Debt)
-86.01-95.98-64.92
Net Cash Growth
---
Net Cash Per Share
-3.21-3.87-2.93
Filing Date Shares Outstanding
28.9424.721.96
Total Common Shares Outstanding
28.9424.721.96
Working Capital
168.23271.36203.7
Book Value Per Share
26.7731.3421.51
Tangible Book Value
767.27765.8463.13
Tangible Book Value Per Share
26.5231.0121.09